# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016654
Filing Date
2023-05-02
Accepted
2023-05-02 16:02:32
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | srpt-20230331.htm iXBRL | 10-Q | 3711821
2 | EX-31.1 | srpt-ex31_1.htm | EX-31 | 15229
3 | EX-31.2 | srpt-ex31_2.htm | EX-31 | 15336
4 | EX-32.1 | srpt-ex32_1.htm | EX-32 | 10902
5 | EX-32.2 | srpt-ex32_2.htm | EX-32 | 10717
| Complete submission text file | 0000950170-23-016654.txt |  | 12120535

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | srpt-20230331_pre.xml | EX-101.PRE | 381599
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | srpt-20230331_cal.xml | EX-101.CAL | 71435
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | srpt-20230331.xsd | EX-101.SCH | 72532
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | srpt-20230331_lab.xml | EX-101.LAB | 498231
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | srpt-20230331_def.xml | EX-101.DEF | 228375
72 | EXTRACTED XBRL INSTANCE DOCUMENT | srpt-20230331_htm.xml | XML | 2507177

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 23878790
SIC: 2834 Pharmaceutical Preparations